HS-10296
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for HS-10296, covering 2022-07-07 to 2023-01-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Safety, PK and Efficacy of HS-10296 in Patients With NSCLC [Phase 1, Phase 2]